To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RFC5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
515 supporting clones for gene RFC5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL550356 placenta, Placenta Cot 25-normalized .a 1 to 906 1 to 905   tiling clone,   905/979
(92 %)
3 diff
(99.7 %id)
AL574377 placenta, Placenta Cot 25-normalized .a 903 to 1821 918 to 1   tiling clone,   918/1044
(87 %)
7 diff
(99.4 %id)
AA463340.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 915 to 1371 1 to 456   tiling clone, also hits gene FILIP1L 456/456
(100 %)
1 diff
(99.8 %id)
BQ336283 marrow .a 964 to 1319 360 to 4       357/360
(99 %)
0 diff
(100 %id)
FN089255 breast carcinoma .a 1065 to 1143 81 to 2     Submitted on the opposite strand 80/82
(97 %)
0 diff
(100 %id)
BX481359   .a 1277 to 1834 600 to 41   tiling clone, AAA Submitted on the opposite strand 560/560
(100 %)
3 diff
(99.5 %id)
AI870564 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1649 to 1832 202 to 19   tiling clone, AAA   184/184
(100 %)
0 diff
(100 %id)
DA345994 substantia nigra .b 1 to 590 4 to 593   tiling clone, capped   592/592
(100 %)
1 diff
(99.9 %id)
CD691854 normal nasopharynx .b 1 to 554 37 to 590       556/590
(94 %)
6 diff
(99.0 %id)
DB445109 testis .b 1 to 431 3 to 431       431/431
(100 %)
4 diff
(99.1 %id)
NM_007370.4   .b 1 to 2101 3 to 2103 exact RefSeq, AAA   2103/2103
(100 %)
0 diff
(100 %id)
BP374880 umbilical cord .b 1 to 581 3 to 583       583/583
(100 %)
0 diff
(100 %id)
DB263415 uterus .b 1 to 544 4 to 548   capped   547/548
(99 %)
1 diff
(99.9 %id)
DA250703 caudate nucleus .b 1 to 524 47 to 570   capped   525/569
(92 %)
6 diff
(99.0 %id)
AU100185   .b 1 to 299 2 to 300       300/300
(100 %)
3 diff
(99.0 %id)
BP331754 renal proximal tubule .b 1 to 583 2 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BP342262 stomach mucosa .b 1 to 581 2 to 582       582/582
(100 %)
0 diff
(100 %id)
DB270923 uterus .b 1 to 533 3 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA037431   .b 1 to 553 2 to 554   capped   553/553
(100 %)
6 diff
(99.0 %id)
DA585085 lung .b 1 to 539 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA716860   .b 1 to 382 2 to 386   capped   385/385
(100 %)
3 diff
(99.3 %id)
DB000227 breast, tumor tissue .b 1 to 518 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DB003029 breast, tumor tissue .b 1 to 544 2 to 545   capped   544/545
(99 %)
0 diff
(100 %id)
BM153733 leukopheresis .b 1 to 387 1 to 386       386/407
(94 %)
15 diff
(96.4 %id)
DA946698 Spleen .b 2 to 582 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA135602 alzheimer cortex .b 3 to 548 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DB104360 thymus .b 3 to 553 2 to 552   capped   551/551
(100 %)
6 diff
(99.0 %id)
DB114301 thymus .b 3 to 565 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB249097 uterus .b 3 to 504 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
BP249652 Kidney .b 4 to 596 1 to 593       593/593
(100 %)
3 diff
(99.5 %id)
BI838951 pooled pancreas and spleen .b 4 to 703 1 to 699       699/699
(100 %)
2 diff
(99.8 %id)
TI_57167125   .b 4 to 703 1 to 699       699/699
(100 %)
2 diff
(99.8 %id)
BI835603 pooled pancreas and spleen .b 5 to 786 1 to 780       780/786
(99 %)
8 diff
(99.0 %id)
AK291107   .b 6 to 1660 1 to 1648 A13V T69*     1648/1648
(100 %)
7 diff
(99.6 %id)
BP201355 amygdala .b 6 to 587 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP368508 thymus .b 6 to 559 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
DA385840 thalamus .b 7 to 598 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
CB120818 cervix, Uterine .b 7 to 695 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
DA419819 cord Blood .b 7 to 568 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA478527   .b 7 to 559 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA499929 brain .b 7 to 577 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA559303   .b 7 to 563 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
AU127885   .b 7 to 704 2 to 691   capped Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 690/701
(98 %)
16 diff
(97.8 %id)
DA816130   .b 7 to 577 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA902225   .b 7 to 558 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA907028   .b 7 to 572 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA925132 small intestine .b 7 to 588 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DB018185 esophageal, tumor tissue .b 7 to 574 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB107569 thymus .b 7 to 573 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB108761 thymus .b 7 to 574 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB123773 thymus .b 7 to 640 2 to 637   capped   636/636
(100 %)
2 diff
(99.7 %id)
DB125675 thymus .b 7 to 518 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
DB173139 kidney, tumor tissue .b 7 to 580 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA904960   .b 13 to 563 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA915484   .b 13 to 564 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BP367591 thymus .b 14 to 595 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA150769 amygdala .b 15 to 586 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AL532485 brain, fetal liver, Liver, neuroblastoma cells .b 15 to 817 1 to 803   fully sequenced,   803/803
(100 %)
2 diff
(99.8 %id)
BU942095 mixed (pool of 40 RNAs) .b 15 to 704 1 to 698       698/789
(88 %)
20 diff
(97.5 %id)
AL583073 B cells from Burkitt lymphoma .b 16 to 554 1 to 547       547/716
(76 %)
26 diff
(96.4 %id)
AA460085   .b 17 to 481 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
BM801393 duodenal adenocarcinoma, cell line, small intestine .b 18 to 782 1 to 771       771/905
(85 %)
17 diff
(98.2 %id)
DB123919 thymus .b 18 to 579 30 to 591   capped   562/590
(95 %)
6 diff
(99.0 %id)
AK290685   .b 19 to 1593 1 to 1575 T260A     1575/1575
(100 %)
3 diff
(99.9 %id)
DA476438   .b 19 to 579 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA606857   .b 19 to 527 2 to 511   capped   508/510
(99 %)
3 diff
(99.5 %id)
DA645733 mammary gland .b 19 to 809 2 to 792   capped   791/791
(100 %)
5 diff
(99.4 %id)
DA745891   .b 19 to 592 2 to 575   capped   574/575
(99 %)
1 diff
(99.9 %id)
DB128961 thymus .b 19 to 570 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DB188684 liver, tumor tissue .b 19 to 595 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA032078   .b 20 to 594 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AU118234 whole embryo, mainly head .b 20 to 868 2 to 850   capped   849/849
(100 %)
5 diff
(99.5 %id)
DA579074   .b 20 to 589 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA910472   .b 20 to 581 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB112572 thymus .b 20 to 597 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA004203   .b 22 to 592 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA172447 amygdala .b 22 to 485 97 to 562   capped   466/561
(83 %)
6 diff
(99.0 %id)
BC001866 Skin, melanotic melanoma. .b 23 to 2101 1 to 2079 exact available from MGC, AAA   2079/2079
(100 %)
0 diff
(100 %id)
BQ069409 brain, neuroblastoma, cell line .b 23 to 540 1 to 520       520/1320
(39 %)
14 diff
(99.0 %id)
BM923289 pooled colon, kidney, stomach .b 24 to 996 13 to 989       977/1044
(93 %)
26 diff
(97.6 %id)
DA910616   .b 24 to 584 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA538442 Kidney .b 25 to 600 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA382878 thalamus .b 26 to 657 2 to 633   capped   632/632
(100 %)
0 diff
(100 %id)
AW651734 cervical carcinoma cell line, cervix .b 26 to 597 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BE622320 melanotic melanoma, skin .b 26 to 642 1 to 617       617/906
(68 %)
6 diff
(99.4 %id)
CX163390 human embryonic stem cells differentiated toan early endodermal cell type .b 26 to 859 1 to 834       834/834
(100 %)
5 diff
(99.5 %id)
DA749206   .b 26 to 595 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB005225 breast, tumor tissue .b 26 to 565 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DB110652 thymus .b 26 to 600 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB116649 thymus .b 26 to 565 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA606365   .b 27 to 588 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB016563 esophageal, tumor tissue .b 28 to 593 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AA312391   .b 30 to 382 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
CV572971 cornea, eye .b 30 to 589 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BG766412 melanotic melanoma, high MDR (cell line), skin .b 31 to 697 1 to 667       667/667
(100 %)
3 diff
(99.6 %id)
AA290858 ovarian tumor, ovary .b 33 to 480 14 to 461       448/461
(97 %)
6 diff
(98.7 %id)
TI_57151045   .b 33 to 636 24 to 627       604/627
(96 %)
9 diff
(98.6 %id)
DN994333 brain, whole brain .b 33 to 509 1 to 486       484/486
(99 %)
12 diff
(97.6 %id)
CX754843 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 34 to 747 1 to 702     Submitted on the opposite strand 702/752
(93 %)
11 diff
(98.6 %id)
BQ427429 melanotic melanoma, skin .b 35 to 339 1 to 308       308/977
(31 %)
5 diff
(99.5 %id)
BF172271 blood .b 37 to 359 1 to 320       320/324
(98 %)
8 diff
(97.6 %id)
BI762441 pooled colon, kidney, stomach .b 38 to 636 1 to 600       600/600
(100 %)
8 diff
(98.7 %id)
BC013961 Muscle, rhabdomyosarcoma .b 39 to 1973 1 to 1935 exact available from MGC, AAA   1935/1935
(100 %)
0 diff
(100 %id)
N40870 placenta .b 39 to 464 1 to 428       428/504
(84 %)
12 diff
(97.7 %id)
BG825474 muscle, rhabdomyosarcoma .b 39 to 719 1 to 682       682/682
(100 %)
8 diff
(98.9 %id)
BU179190 melanotic melanoma, cell line, skin .b 39 to 713 1 to 677       677/942
(71 %)
13 diff
(98.7 %id)
BG698981 brain, hippocampus .b 40 to 655 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
CN349259 embryonic stem cells, DMSO-treated H9 cellline .b 41 to 455 9 to 423       415/423
(98 %)
6 diff
(98.6 %id)
BI088889 cervix .b 41 to 613 1 to 584       584/794
(73 %)
26 diff
(96.8 %id)
BM011886 brain, neuroblastoma, cell line .b 41 to 725 1 to 682       682/683
(99 %)
6 diff
(99.2 %id)
TI_59381067   .b 41 to 725 94 to 775       682/683
(99 %)
6 diff
(99.2 %id)
H72767 liver and spleen .b 42 to 431 1 to 395       392/398
(98 %)
16 diff
(96.0 %id)
BE250566 muscle, rhabdomyosarcoma .b 42 to 841 7 to 802       796/802
(99 %)
10 diff
(98.8 %id)
BE781077 eye, retinoblastoma .b 42 to 704 1 to 655       655/949
(69 %)
14 diff
(98.6 %id)
BE276810 melanotic melanoma, skin .b 44 to 471 1 to 426       426/426
(100 %)
2 diff
(99.6 %id)
DN913960   .b 45 to 619 1 to 575       575/575
(100 %)
6 diff
(99.0 %id)
BF026551 melanotic melanoma, skin .b 45 to 786 1 to 740       740/945
(78 %)
18 diff
(98.1 %id)
BQ881971 brain, neuroblastoma, cell line .b 47 to 785 25 to 766       742/914
(81 %)
17 diff
(98.2 %id)
CX761069 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 48 to 704 30 to 686     Submitted on the opposite strand 657/714
(92 %)
14 diff
(98.1 %id)
BX346312   .b 49 to 1039 1 to 989       989/989
(100 %)
5 diff
(99.5 %id)
BC021205 Muscle, rhabdomyosarcoma .b 50 to 1973 2674 to 4597 exact tiling clone, AAA   1924/4597
(41 %)
5 diff
(99.9 %id)
BE543388 cervical carcinoma cell line, cervix .b 51 to 693 1 to 642       642/642
(100 %)
4 diff
(99.4 %id)
BM904897 melanotic melanoma, skin .b 51 to 679 23 to 660       638/1112
(57 %)
22 diff
(98.1 %id)
CX756665 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 51 to 783 1 to 733     Submitted on the opposite strand 733/733
(100 %)
2 diff
(99.8 %id)
BU657689 blood .b 52 to 585 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
CA390335 eye, RPE/choroid .b 53 to 623 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BU178209 melanotic melanoma, skin .b 55 to 710 1 to 656       656/904
(72 %)
6 diff
(99.4 %id)
BE797316 lung, small cell carcinoma .b 59 to 715 1 to 657       657/657
(100 %)
0 diff
(100 %id)
BJ996473 hepatoblastoma .b 61 to 504 1 to 444       444/444
(100 %)
0 diff
(100 %id)
AU130167   .b 61 to 836 2 to 780   capped   779/779
(100 %)
3 diff
(99.7 %id)
BC020440 Placenta, choriocarcinoma .b 66 to 2101 1 to 2036 exact available from MGC, AAA   2036/2036
(100 %)
1 diff
(100.0 %id)
BX354909 Neuroblastoma Cot 25-normalized .b 71 to 1050 1 to 981       981/981
(100 %)
4 diff
(99.6 %id)
BQ226753 embryonal carcinoma, cell line, testis .b 92 to 936 1 to 845       845/845
(100 %)
3 diff
(99.7 %id)
L07540   .b 115 to 1361 1 to 1244 exact     1244/1244
(100 %)
7 diff
(99.5 %id)
TI_1948122065   .b 123 to 575 126 to 578   fully sequenced,   453/578
(78 %)
6 diff
(99.0 %id)
TI_1948122234   .b 123 to 575 128 to 580   fully sequenced,   453/580
(78 %)
6 diff
(99.0 %id)
TI_1948122415   .b 123 to 1144 129 to 1146   fully sequenced,   1016/1144
(88 %)
36 diff
(96.9 %id)
TI_1948122585   .b 123 to 575 127 to 579   fully sequenced,   453/579
(78 %)
6 diff
(99.0 %id)
CR407651   .b 124 to 1143 1 to 1020       1020/1020
(100 %)
1 diff
(100.0 %id)
TI_57167203   .b 189 to 786 216 to 812       796/818
(97 %)
13 diff
(98.5 %id)
TI_1948122066   .b 514 to 1145 755 to 124   fully sequenced,   632/755
(83 %)
0 diff
(100 %id)
TI_1948122235   .b 514 to 1145 754 to 123   fully sequenced,   632/754
(83 %)
0 diff
(100 %id)
TI_1948122586   .b 514 to 1145 758 to 127   fully sequenced,   632/758
(83 %)
0 diff
(100 %id)
TI_1948122416   .b 674 to 1145 597 to 126   fully sequenced,   472/597
(79 %)
0 diff
(100 %id)
AL564404 brain, fetal liver, Liver, neuroblastoma cells .b 756 to 1512 757 to 1   fully sequenced,   757/757
(100 %)
10 diff
(98.7 %id)
BX346311   .b 1056 to 2068 1013 to 1       1013/1016
(99 %)
9 diff
(99.2 %id)
BE250399 muscle, rhabdomyosarcoma .b 1082 to 1920 849 to 5       845/1015
(83 %)
0 diff
(100 %id)
AA283772 ovarian tumor, ovary .b 1165 to 1563 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AL583072 B cells from Burkitt lymphoma .b 1227 to 2067 842 to 1       842/842
(100 %)
67 diff
(92.1 %id)
DB356275 whole embryo, mainly head .b 1522 to 2101 574 to 1       574/574
(100 %)
20 diff
(96.6 %id)
DB367413   .b 1589 to 2103 513 to 1       513/544
(94 %)
4 diff
(99.3 %id)
DB364944   .b 1591 to 2101 509 to 1     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 509/547
(93 %)
14 diff
(97.5 %id)
CX163326 human embryonic stem cells differentiated toan early endodermal cell type .b 1650 to 2103 477 to 24   AAA   454/454
(100 %)
3 diff
(99.4 %id)
AW673196 cervical carcinoma cell line, cervix .b 1666 to 2101 436 to 1       436/436
(100 %)
0 diff
(100 %id)
BJ996474 hepatoblastoma .b 1669 to 2066 398 to 1       398/398
(100 %)
0 diff
(100 %id)
DB321519 mammary gland .b 1738 to 2101 364 to 1       364/368
(98 %)
8 diff
(97.9 %id)
AA459991   .b 1785 to 2101 332 to 16   AAA   317/317
(100 %)
0 diff
(100 %id)
AU127915   .c 1 to 521 2 to 515   tiling clone, capped   514/514
(100 %)
4 diff
(99.3 %id)
AB208992 brain .c 35 to 2080 1 to 2046 exact tiling clone,   2046/2046
(100 %)
0 diff
(100 %id)
BM698354 eye, fetal eyes .c 42 to 512 1 to 471       471/471
(100 %)
0 diff
(100 %id)
BX385628.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1258 to 2169 1 to 907     also hits gene CX3CL1 907/934
(97 %)
36 diff
(96.2 %id)
AL525471 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1258 to 2325 1 to 1057   tiling clone,   1057/1057
(100 %)
17 diff
(98.4 %id)
BX372867 Neuroblastoma Cot 25-normalized .c 1282 to 2083 811 to 1       811/929
(87 %)
25 diff
(97.4 %id)
BU621394 cell lines, Chondrosarcoma .c 1465 to 2086 640 to 19   AAA   622/622
(100 %)
1 diff
(99.9 %id)
TI_153987851   .c 1479 to 2086 696 to 92   AAA   605/623
(97 %)
43 diff
(93.1 %id)
AI741647 pooled .c 1519 to 2099 581 to 1       581/581
(100 %)
12 diff
(98.0 %id)
DB365962   .c 1526 to 2079 557 to 1       557/561
(99 %)
16 diff
(97.2 %id)
BE645041 pooled .c 1527 to 2082 561 to 6       556/561
(99 %)
0 diff
(100 %id)
AW026559 brain, glioblastoma (pooled) .c 1534 to 2086 553 to 1       553/553
(100 %)
0 diff
(100 %id)
BE670264 carcinoid, lung .c 1536 to 2092 558 to 2       557/558
(99 %)
0 diff
(100 %id)
DB364985   .c 1538 to 2086 547 to 1       547/556
(98 %)
10 diff
(98.3 %id)
BU736110 eye, fetal eyes .c 1541 to 2086 564 to 19   AAA   546/546
(100 %)
2 diff
(99.7 %id)
BX354908 Neuroblastoma Cot 25-normalized .c 1550 to 2027 482 to 1       482/623
(77 %)
13 diff
(98.0 %id)
CN349262 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1562 to 2082 1 to 521       521/524
(99 %)
1 diff
(99.9 %id)
AI984944 Kidney .c 1585 to 2077 494 to 1       494/494
(100 %)
3 diff
(99.4 %id)
CF130370 Chondrosarcoma Lung Metastasis cell lines, lung .c 1586 to 2086 1 to 501   AAA   501/501
(100 %)
0 diff
(100 %id)
TI_154192339   .c 1586 to 2086 51 to 551   AAA   501/501
(100 %)
0 diff
(100 %id)
BM145227 leukopheresis .c 1602 to 2086 500 to 17   AAA   484/484
(100 %)
7 diff
(98.6 %id)
AI567945 ovary, tumor, 5 pooled (see description) .c 1604 to 2088 511 to 27   AAA   485/485
(100 %)
0 diff
(100 %id)
AW055070 brain, glioblastoma (pooled) .c 1604 to 2086 483 to 1       483/483
(100 %)
0 diff
(100 %id)
BF111448 pooled .c 1605 to 2092 490 to 3       488/490
(99 %)
0 diff
(100 %id)
AW243483 Kidney .c 1616 to 2086 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AI686195 Prostate .c 1622 to 2087 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI830445 Kidney .c 1623 to 2087 467 to 2       466/467
(99 %)
0 diff
(100 %id)
AA447149   .c 1630 to 2086 475 to 22   AAA   454/454
(100 %)
6 diff
(98.7 %id)
AI589157 brain, glioblastoma (pooled) .c 1639 to 2086 448 to 1       448/448
(100 %)
3 diff
(99.4 %id)
BQ024548 placenta .c 1651 to 2080 448 to 19   AAA   430/430
(100 %)
0 diff
(100 %id)
AA954408 pooled .c 1656 to 2086 444 to 15   AAA   430/430
(100 %)
3 diff
(99.4 %id)
AI913853 colon .c 1672 to 2086 428 to 14   AAA   415/415
(100 %)
2 diff
(99.6 %id)
AI659766 Prostate .c 1696 to 2086 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
AI913510 Kidney .c 1697 to 2087 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
AW134575   .c 1702 to 2086 402 to 18   AAA   385/385
(100 %)
0 diff
(100 %id)
AI369570   .c 1704 to 2079 379 to 4       376/379
(99 %)
0 diff
(100 %id)
BM741086 Ascites, stomach .c 1709 to 2035 1 to 327       327/327
(100 %)
0 diff
(100 %id)
AI339030 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1715 to 2086 393 to 22   AAA   372/372
(100 %)
11 diff
(97.1 %id)
AA830256 germinal center B cell .c 1723 to 2086 376 to 13   AAA   364/364
(100 %)
0 diff
(100 %id)
AA282758.
matches multiple genes
germinal center B cell .c 1724 to 2089 366 to 1     also hits gene SERF2andC15orf63 366/366
(100 %)
2 diff
(99.5 %id)
AW134951   .c 1730 to 2086 374 to 18   AAA   357/357
(100 %)
0 diff
(100 %id)
AI383180   .c 1732 to 2086 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AW204217   .c 1767 to 2086 337 to 18   AAA   320/320
(100 %)
5 diff
(98.5 %id)
AA973134 pooled .c 1769 to 2087 322 to 3       320/322
(99 %)
0 diff
(100 %id)
AI498032 anaplastic oligodendroglioma, brain .c 1778 to 2086 321 to 13   AAA   309/309
(100 %)
0 diff
(100 %id)
AI913797 pooled .c 1779 to 2087 311 to 3       309/311
(99 %)
0 diff
(100 %id)
BF594665 brain, glioblastoma (pooled) .c 1796 to 2086 291 to 1       291/291
(100 %)
0 diff
(100 %id)
AI580717 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1801 to 2086 286 to 1       286/286
(100 %)
0 diff
(100 %id)
NM_001130113.1   .d 1 to 2160 3 to 2162 exact RefSeq, AAA   2162/2162
(100 %)
0 diff
(100 %id)
DA072376 cerebellum .d 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
CB266982 adipose .d 17 to 577 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BU169958 large cell carcinoma, lung .d 316 to 1155 1 to 845       845/896
(94 %)
7 diff
(99.3 %id)
AW959369   .d 332 to 1029 1 to 699       699/699
(100 %)
9 diff
(98.8 %id)
DT220476 brain .d 461 to 1127 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
BP272016   .d 461 to 1034 1 to 574       574/574
(100 %)
5 diff
(99.2 %id)
BI254728 cervical carcinoma cell line, cervix .d 530 to 1214 1 to 685   tiling clone,   685/685
(100 %)
1 diff
(99.9 %id)
BG938493 Bone, Hip .d 551 to 1058 9 to 516       508/516
(98 %)
6 diff
(98.9 %id)
TI_154138017   .d 587 to 1175 72 to 662       559/591
(94 %)
24 diff
(96.0 %id)
F06914 brain, total brain .d 601 to 900 1 to 300       300/300
(100 %)
3 diff
(99.0 %id)
R54371 whole brain .d 697 to 1046 1 to 353       353/431
(81 %)
13 diff
(97.0 %id)
H10531 whole brain .d 697 to 1055 1 to 366       366/465
(78 %)
11 diff
(97.7 %id)
H29116 whole brain .d 697 to 956 1 to 260       260/260
(100 %)
2 diff
(99.3 %id)
BM465357 eye, retinoblastoma .d 710 to 1269 1 to 559       559/1177
(47 %)
8 diff
(99.4 %id)
BM474260 leiomyosarcoma, uterus .d 723 to 1639 1 to 921       921/987
(93 %)
15 diff
(98.5 %id)
BU634362 cell lines, Chondrosarcoma .d 736 to 1423 706 to 19   AAA   688/688
(100 %)
0 diff
(100 %id)
BI334246 cervical carcinoma cell line, cervix .d 747 to 1603 1 to 855       855/855
(100 %)
9 diff
(99.0 %id)
BE909550 epithelioid carcinoma, Pancreas .d 767 to 1390 1 to 627       627/627
(100 %)
6 diff
(99.1 %id)
CN349267 embryonic stem cells, DMSO-treated H9 cellline .d 802 to 1321 1 to 520       520/520
(100 %)
0 diff
(100 %id)
BG164236 hypernephroma, cell line, Kidney .d 834 to 1599 1 to 767       767/1028
(74 %)
29 diff
(97.2 %id)
BG340114 leiomyosarcoma cell line, uterus .d 836 to 1398 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BU594933 mixed (pool of 40 RNAs) .d 895 to 1693 1 to 809       809/816
(99 %)
13 diff
(98.5 %id)
AV650479 corresponding non cancerous liver tissue .d 920 to 1496 1 to 575     Submitted on the opposite strand 575/753
(76 %)
13 diff
(98.3 %id)
FN064798 breast carcinoma .d 925 to 1022 98 to 1     Submitted on the opposite strand 98/98
(100 %)
0 diff
(100 %id)
AV650752 corresponding non cancerous liver tissue .d 926 to 1323 1 to 398     Submitted on the opposite strand 398/398
(100 %)
0 diff
(100 %id)
CN349263 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 980 to 1728 1 to 752       752/752
(100 %)
6 diff
(99.3 %id)
CN349265 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 991 to 1749 1 to 759   tiling clone,   759/759
(100 %)
0 diff
(100 %id)
AI572894 lymph node, lymphoma, follicular mixed small and largecell .d 1001 to 1624 623 to 2       622/623
(99 %)
3 diff
(99.6 %id)
AW772505 Kidney .d 1001 to 1622 633 to 13   AAA   621/623
(99 %)
4 diff
(99.4 %id)
AI937511 anaplastic oligodendroglioma, brain .d 1023 to 1622 600 to 1       600/600
(100 %)
1 diff
(99.9 %id)
BG622081 placenta .d 1025 to 1622 1 to 599   AAA   599/599
(100 %)
4 diff
(99.4 %id)
BI259139 cervical carcinoma cell line, cervix .d 1064 to 1767 1 to 706       706/706
(100 %)
6 diff
(99.2 %id)
AA972893 pooled .d 1068 to 1622 554 to 1       554/554
(100 %)
6 diff
(99.0 %id)
AA860777 parathyroid gland, parathyroid tumor .d 1105 to 1624 525 to 8       518/571
(90 %)
0 diff
(100 %id)
BG287106 bladder, transitional cell papilloma, cell line .d 1105 to 1779 9 to 684       676/971
(69 %)
9 diff
(99.1 %id)
BF036943 adenocarcinoma, ovary .d 1113 to 1851 1 to 746       746/932
(80 %)
29 diff
(96.9 %id)
AI932225 anaplastic oligodendroglioma, brain .d 1125 to 1624 506 to 7       500/506
(98 %)
0 diff
(100 %id)
CB149469 Liver .d 1147 to 1622 1 to 476   AAA   476/476
(100 %)
2 diff
(99.6 %id)
BE045377 carcinoid, lung .d 1162 to 1648 1 to 487     Submitted on the opposite strand 487/487
(100 %)
0 diff
(100 %id)
AI911058 pooled .d 1219 to 1626 410 to 3       408/410
(99 %)
0 diff
(100 %id)
TI_154126399   .d 1229 to 2044 913 to 104   AAA   810/950
(85 %)
13 diff
(98.7 %id)
BU953739 mixed (pool of 40 RNAs) .d 1256 to 1628 1 to 373       373/412
(90 %)
2 diff
(99.6 %id)
AI300265 placenta .d 1285 to 1624 342 to 3       340/343
(99 %)
0 diff
(100 %id)
AI520804 adenocarcinoma, Pancreas .d 1286 to 1625 340 to 1       340/340
(100 %)
3 diff
(99.2 %id)
AA587624 colon, colon tumor RER+ .d 1354 to 1624 272 to 2       271/272
(99 %)
0 diff
(100 %id)
AA857650 adenocarcinoma, colon .d 1355 to 1623 269 to 1       269/269
(100 %)
0 diff
(100 %id)
CA416544 Chondrosarcoma Cell line .d 1387 to 2044 677 to 19   tiling clone, AAA   659/659
(100 %)
3 diff
(99.6 %id)
CB162248 Liver .d 1447 to 2039 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BE622783 melanotic melanoma, skin .d 1462 to 2109 681 to 2       680/684
(99 %)
0 diff
(100 %id)
BE549666 carcinoid, lung .d 1473 to 2017 1 to 545     Submitted on the opposite strand 545/545
(100 %)
1 diff
(99.9 %id)
BE670595 carcinoid, lung .d 1475 to 2004 1 to 530     Submitted on the opposite strand 530/530
(100 %)
1 diff
(99.9 %id)
BF438149 carcinoid, lung .d 1475 to 1977 1 to 504     Submitted on the opposite strand 504/504
(100 %)
2 diff
(99.7 %id)
BE220451 carcinoid, lung .d 1477 to 1994 1 to 518     Submitted on the opposite strand 518/518
(100 %)
0 diff
(100 %id)
BE467903 carcinoid, lung .d 1477 to 1852 1 to 376     Submitted on the opposite strand 376/376
(100 %)
0 diff
(100 %id)
AA478786 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1517 to 2027 530 to 19   AAA   512/512
(100 %)
15 diff
(97.1 %id)
FN082965 breast carcinoma .d 1537 to 1625 86 to 1     Submitted on the opposite strand 86/87
(98 %)
3 diff
(96.6 %id)
AI651635 pooled germ cell tumors .d 1539 to 2032 494 to 1       494/494
(100 %)
9 diff
(98.2 %id)
AW086459 ovary, papillary serous carcinoma .d 1541 to 2034 503 to 10       494/503
(98 %)
0 diff
(100 %id)
AA282864.
matches multiple genes
germinal center B cell .d 1553 to 1883 1 to 331     This clone was ignored, also hits gene bleyzubu 331/331
(100 %)
2 diff
(99.4 %id)
AI393093 B-cell, chronic lymphotic leukemia .d 1559 to 2048 492 to 4       489/492
(99 %)
0 diff
(100 %id)
BQ013335 placenta .d 1581 to 2044 482 to 19   AAA   464/464
(100 %)
0 diff
(100 %id)
AI203350 pooled germ cell tumors .d 1593 to 2032 443 to 4       440/443
(99 %)
0 diff
(100 %id)
AI241494 liver and spleen .d 1649 to 2032 393 to 10       384/393
(97 %)
0 diff
(100 %id)
DW408710 Liver .d 1667 to 1992 17 to 342       326/342
(95 %)
6 diff
(98.3 %id)
AI270172 colon, moderately-differentiated adenocarcinoma .d 1699 to 2032 344 to 9       336/344
(97 %)
0 diff
(100 %id)
H29015 whole brain .d 1775 to 2160 417 to 27   tiling clone, AAA   391/393
(99 %)
15 diff
(96.2 %id)
FN060468 breast carcinoma .d 1776 to 1862 1 to 88       88/89
(98 %)
4 diff
(95.6 %id)
BM544076 ovary (pool of 3) .d 1785 to 2044 1 to 260   AAA   260/260
(100 %)
0 diff
(100 %id)
H10350 whole brain .d 1842 to 2160 344 to 26   AAA   319/319
(100 %)
3 diff
(99.1 %id)
AW242919 Kidney .d 1866 to 2032 179 to 13   AAA   167/167
(100 %)
0 diff
(100 %id)
AA682666 liver and spleen .d 1905 to 2032 128 to 1       128/128
(100 %)
0 diff
(100 %id)
FN058383 breast carcinoma .d 1947 to 2033 83 to 1     Submitted on the opposite strand 83/84
(98 %)
5 diff
(94.1 %id)
FN121249 breast carcinoma .d 1957 to 2031 74 to 1     Submitted on the opposite strand 74/74
(100 %)
1 diff
(98.7 %id)
Z39981 brain, total brain .d 1963 to 2160 198 to 1       198/198
(100 %)
0 diff
(100 %id)
BM770807 Ascites, stomach .d 2062 to 2160 1 to 98   AAA   98/98
(100 %)
1 diff
(99.0 %id)
DA533240 brain .e 1 to 563 4 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
NM_181578.2   .e 1 to 2465 3 to 2467 exact RefSeq, AAA   2467/2467
(100 %)
0 diff
(100 %id)
DA299066 hippocampus .e 1 to 575 3 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA309382 hippocampus .e 7 to 474 2 to 469   capped   468/468
(100 %)
2 diff
(99.6 %id)
BQ954403 large cell carcinoma, lung .e 9 to 907 1 to 900   tiling clone,   900/900
(100 %)
6 diff
(99.4 %id)
AK094575 amygdala .e 18 to 2459 1 to 2442 exact tiling clone, available from FLJ,   2442/2442
(100 %)
4 diff
(99.9 %id)
DA151573 amygdala .e 19 to 598 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DN994430 brain, whole brain .e 32 to 636 9 to 613       605/613
(98 %)
7 diff
(98.9 %id)
BF303824 muscle, rhabdomyosarcoma .e 38 to 752 1 to 717       717/904
(79 %)
20 diff
(97.8 %id)
BF204869 muscle, rhabdomyosarcoma .e 39 to 689 1 to 645       645/920
(70 %)
28 diff
(97.0 %id)
BE265309 lung, small cell carcinoma .e 51 to 693 1 to 641       641/706
(90 %)
9 diff
(98.8 %id)
BE269895 Burkitt lymphoma, lymph .e 57 to 372 1 to 319       319/919
(34 %)
7 diff
(99.3 %id)
BE295911 muscle, rhabdomyosarcoma .e 59 to 609 1 to 552       552/552
(100 %)
2 diff
(99.7 %id)
BE296230 muscle, rhabdomyosarcoma .e 59 to 693 1 to 634       634/642
(98 %)
4 diff
(99.4 %id)
DA505932 brain .e 62 to 610 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
BI115297 muscle, rhabdomyosarcoma .e 77 to 818 1 to 741       741/742
(99 %)
12 diff
(98.4 %id)
BG824015 adenocarcinoma cell line, colon .e 82 to 828 1 to 748       748/748
(100 %)
4 diff
(99.5 %id)
AU077168   .f 1 to 155 1 to 155   tiling clone,   155/155
(100 %)
0 diff
(100 %id)
AU107616   .f 1 to 50 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BM172401 melanotic melanoma, high MDR (cell line), skin .f 4 to 152 1 to 150       150/150
(100 %)
10 diff
(93.4 %id)
BU162275 leiomyosarcoma, uterus .f 5 to 835 1 to 833       833/833
(100 %)
2 diff
(99.8 %id)
BX463274 fetal liver, Liver .f 9 to 878 1 to 870       870/873
(99 %)
28 diff
(96.8 %id)
BM475899 eye, retinoblastoma .f 19 to 902 1 to 883 T261Q A262P Y263T R264K S265I tiling clone,   883/1032
(85 %)
9 diff
(99.2 %id)
BQ218788 embryonal carcinoma, cell line, testis .f 20 to 856 1 to 842       842/847
(99 %)
7 diff
(99.2 %id)
BM017634 astrocytoma grade IV, cell line, brain .f 21 to 830 1 to 816       813/816
(99 %)
25 diff
(97.0 %id)
BM463996 melanotic melanoma, skin .f 21 to 901 1 to 891 S209F S210Q G211W D212R M213H ...     891/1111
(80 %)
24 diff
(97.9 %id)
TI_59388139   .f 22 to 830 99 to 913       812/815
(99 %)
24 diff
(97.1 %id)
FN139881 breast carcinoma .f 23 to 95 1 to 74       74/74
(100 %)
2 diff
(97.3 %id)
CD657120 Embryonic Stem cells .f 30 to 835 12 to 810       799/825
(96 %)
22 diff
(97.4 %id)
CX867861 embryonic stem .f 31 to 789 1 to 759       759/759
(100 %)
0 diff
(100 %id)
BG386327 adenocarcinoma cell line, colon .f 32 to 802 1 to 781       780/1083
(72 %)
22 diff
(98.0 %id)
CX784803 human embryonic stem cells .f 32 to 788 1 to 757       757/757
(100 %)
0 diff
(100 %id)
BM470463 eye, retinoblastoma .f 37 to 902 1 to 875 T64I E192R E193R K194E V195S ...     875/1001
(87 %)
22 diff
(97.9 %id)
BE294544 muscle, rhabdomyosarcoma .f 40 to 686 1 to 680       657/680
(96 %)
41 diff
(94.0 %id)
BX477503   .f 42 to 593 1 to 552       552/552
(100 %)
2 diff
(99.7 %id)
AU107614   .f 43 to 92 1 to 50       50/50
(100 %)
2 diff
(96.0 %id)
BP273584   .f 43 to 615 1 to 573       573/573
(100 %)
4 diff
(99.4 %id)
DA846908 placenta .f 43 to 610 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA847524 placenta .f 43 to 618 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA000842   .f 44 to 560 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
BE252925 eye, retinoblastoma .f 44 to 609 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DA745849   .f 44 to 600 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB071138 testis .f 44 to 575 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
CN349261 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 46 to 751 1 to 706       706/706
(100 %)
1 diff
(99.9 %id)
DA286540 corpus callosum .f 47 to 608 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA381396 thalamus .f 47 to 673 2 to 628   capped   627/627
(100 %)
0 diff
(100 %id)
CN349258 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 51 to 649 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
CN349266 embryonic stem cells, cell lines H1, H7, andH9 .f 51 to 722 1 to 672       672/672
(100 %)
0 diff
(100 %id)
BE883861 leiomyosarcoma, uterus .f 56 to 686 1 to 635       635/635
(100 %)
6 diff
(99.1 %id)
BY796208 eye .f 60 to 653 1 to 594       594/594
(100 %)
5 diff
(99.2 %id)
CD697802 normal nasopharynx .f 62 to 555 1 to 494       494/494
(100 %)
4 diff
(99.2 %id)
BU660137 blood .f 63 to 466 1 to 404       404/404
(100 %)
6 diff
(98.6 %id)
CR747056 melanotic melanoma, skin .f 63 to 565 3 to 504       502/504
(99 %)
4 diff
(99.3 %id)
CX758366 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 66 to 774 1 to 709     Submitted on the opposite strand 709/709
(100 %)
0 diff
(100 %id)
BE407363 choriocarcinoma, placenta .f 70 to 599 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BE545616 cervical carcinoma cell line, cervix .f 72 to 769 1 to 701       701/784
(89 %)
14 diff
(98.3 %id)
DA717771   .f 77 to 654 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
CV025966 mixed .f 106 to 663 1 to 558       558/558
(100 %)
0 diff
(100 %id)
CN349260 embryonic stem cells, DMSO-treated H9 cellline .f 109 to 608 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BQ228673 melanotic melanoma, skin .f 162 to 652 1 to 501       501/1147
(43 %)
17 diff
(98.6 %id)
AW992693 breast_normal .f 164 to 342 182 to 4     Submitted on the opposite strand 179/183
(97 %)
3 diff
(98.4 %id)
BF315443 brain, neuroblastoma .f 167 to 890 1 to 717       717/779
(92 %)
19 diff
(97.6 %id)
EH326409   .f 170 to 240 11 to 82       72/85
(84 %)
4 diff
(95.3 %id)
BE260986 brain, neuroblastoma .f 187 to 535 1 to 353       353/362
(97 %)
8 diff
(97.8 %id)
AI760420 colon, colon tumor, RER+ .f 188 to 890 770 to 65   AAA   706/744
(94 %)
20 diff
(97.4 %id)
AA312891   .f 275 to 589 1 to 319       319/319
(100 %)
5 diff
(98.5 %id)
AA094565   .f 323 to 517 1 to 195       195/195
(100 %)
3 diff
(98.5 %id)
EH340291   .f 373 to 450 1 to 77       77/77
(100 %)
1 diff
(98.8 %id)
FN092822 breast carcinoma .f 380 to 479 1 to 99       99/99
(100 %)
4 diff
(96.0 %id)
DW421801 Liver .f 477 to 756 17 to 296       280/296
(94 %)
6 diff
(98.0 %id)
AA431935   .f 525 to 894 1 to 369   tiling clone,   369/369
(100 %)
4 diff
(99.0 %id)
AU121576 mammary gland .g 1 to 836 5 to 839   tiling clone, capped   838/842
(99 %)
14 diff
(98.4 %id)
NM_001130112.1   .g 1 to 2227 3 to 2229 exact RefSeq, AAA   2229/2229
(100 %)
0 diff
(100 %id)
DA252422 caudate nucleus .g 1 to 579 3 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA582785 lung .g 1 to 602 3 to 604   capped   603/603
(100 %)
3 diff
(99.6 %id)
DA745876   .g 13 to 568 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA378094 thalamus .g 16 to 566 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA167929 amygdala .g 26 to 594 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BE785303 large cell carcinoma, lung .g 33 to 646 1 to 619       619/936
(66 %)
15 diff
(98.4 %id)
DB260797 uterus .g 47 to 597 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA539269 Kidney .g 62 to 647 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA208362 brain .g 65 to 620 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BI767422 pooled lung and spleen .g 151 to 825 156 to 834   tiling clone,   679/834
(81 %)
13 diff
(98.5 %id)
TI_57181362   .g 151 to 825 220 to 898       679/898
(75 %)
13 diff
(98.6 %id)
DB360688 mammary gland .g 1545 to 2111 563 to 1   tiling clone,   563/563
(100 %)
12 diff
(97.9 %id)
DB045382 testis .h 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
CN349264 embryonic stem cells, cell lines H1, H7, andH9 .h 507 to 1187 1 to 682   tiling clone,   682/683
(99 %)
2 diff
(99.8 %id)
DA242989 brain .i-u 1 to 577 2 to 578 A18S T98S tiling clone, capped   577/577
(100 %)
2 diff
(99.7 %id)
DB132039 thymus .i-u 7 to 550 2 to 545 T98S tiling clone, capped   544/544
(100 %)
1 diff
(99.9 %id)
DA241987 brain .i-u 24 to 601 2 to 579 T98S capped   578/578
(100 %)
1 diff
(99.9 %id)
DA861003 placenta .i-u 24 to 415 2 to 394   capped   393/393
(100 %)
1 diff
(99.8 %id)
DA880319 Prostate .i-u 26 to 575 2 to 551 T98S capped   550/550
(100 %)
1 diff
(99.9 %id)
AI276049 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 56 to 238 183 to 1       183/183
(100 %)
0 diff
(100 %id)
CN355566 embryonic stem cells, cell lines H1, H7, andH9 .i-u 103 to 602 1 to 500       500/500
(100 %)
3 diff
(99.4 %id)
AA970788 pooled .i-u 230 to 665 1 to 436   tiling clone, Submitted on the opposite strand 436/436
(100 %)
1 diff
(99.8 %id)
AW452556   .i-u 232 to 707 1 to 476     Submitted on the opposite strand 476/476
(100 %)
2 diff
(99.6 %id)
AA836087 germinal center B cell .i-u 322 to 686 1 to 364       364/364
(100 %)
3 diff
(99.2 %id)
CN412833 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i-u 576 to 1175 1 to 599   tiling clone,   599/599
(100 %)
1 diff
(99.9 %id)
DA311805 hippocampus .i-u 629 to 1159 2 to 536   capped   535/535
(100 %)
5 diff
(99.1 %id)
BF838731 head_neck .i-u 1062 to 1438 384 to 8   tiling clone, Submitted on the opposite strand 377/402
(93 %)
0 diff
(100 %id)
BF838733 head_neck .i-u 1062 to 1442 18 to 398       381/400
(95 %)
6 diff
(98.5 %id)
AW811731 stomach .i-u 1180 to 1762 1 to 583   tiling clone,   583/587
(99 %)
10 diff
(98.3 %id)
DA533908 brain .j 1 to 575 2 to 576   tiling clone, capped   575/576
(99 %)
4 diff
(99.4 %id)
DA473315   .j 26 to 567 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DA270201 caudate nucleus .j 56 to 624 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA763561 tongue .k-u 1 to 212 2 to 213   tiling clone, to resequence, capped   212/212
(100 %)
1 diff
(99.6 %id)
BE674267 carcinoid, lung .k-u 1223 to 1679 1 to 457     Submitted on the opposite strand 457/461
(99 %)
24 diff
(94.8 %id)
BF445050 carcinoid, lung .k-u 1223 to 1733 1 to 512   tiling clone, Submitted on the opposite strand 512/512
(100 %)
1 diff
(99.9 %id)
AI214667 carcinoid, lung .k-u 1227 to 1597 1 to 371     Submitted on the opposite strand 371/371
(100 %)
2 diff
(99.5 %id)
AW820264 stomach .k-u 1348 to 1783 13 to 448       436/448
(97 %)
6 diff
(98.7 %id)
AW820437 stomach .k-u 1358 to 1857 1 to 500   tiling clone,   500/500
(100 %)
5 diff
(99.0 %id)
CN430060 embryonic stem cells, cell lines H1, H7, andH9 .k-u 1520 to 2273 1 to 753   tiling clone,   753/753
(100 %)
1 diff
(99.9 %id)
BF906574 stomach .k-u 1854 to 2001 1 to 148       148/148
(100 %)
5 diff
(96.7 %id)
AW820425 stomach .k-u 1879 to 2063 195 to 11       185/195
(94 %)
0 diff
(100 %id)
AW838497 leiomios .k-u 1879 to 2080 220 to 17       204/220
(92 %)
0 diff
(100 %id)
AA385770 thyroid gland .k-u 2235 to 2501 1 to 267   tiling clone,   267/267
(100 %)
0 diff
(100 %id)
AW451566   .k-u 2321 to 2734 16 to 429     Submitted on the opposite strand 414/429
(96 %)
6 diff
(98.7 %id)
AW299739 Kidney .k-u 2323 to 2807 1 to 485   tiling clone, Submitted on the opposite strand 485/485
(100 %)
2 diff
(99.6 %id)
DB325396 tongue .k-u 3013 to 3589 578 to 1 S71R D72* tiling clone, to resequence,   578/578
(100 %)
4 diff
(99.4 %id)
BM797918 Ascites, stomach .l-u 1 to 451 1 to 451   tiling clone,   451/451
(100 %)
3 diff
(99.4 %id)
DB538124 hippocampus .l-u 10 to 440 429 to 1       429/429
(100 %)
10 diff
(97.7 %id)
AA447038   .l-u 217 to 418 24 to 225   fully sequenced,   202/225
(89 %)
6 diff
(97.4 %id)
DB539300 hippocampus .l-u 221 to 647 426 to 1       426/426
(100 %)
14 diff
(96.8 %id)
BP386638 pancreatic islet .l-u 222 to 713 493 to 1       493/500
(98 %)
1 diff
(99.8 %id)
D11805 Liver .l-u 222 to 586 365 to 1       365/368
(99 %)
0 diff
(100 %id)
BP392816 pancreatic islet .l-u 222 to 719 500 to 1       500/500
(100 %)
2 diff
(99.6 %id)
DB536686 hippocampus .l-u 223 to 629 410 to 1       410/410
(100 %)
5 diff
(98.8 %id)
DB539139 hippocampus .l-u 223 to 660 446 to 4       443/446
(99 %)
0 diff
(100 %id)
DB548854.
matches multiple genes
hippocampus .l-u 223 to 661 439 to 1     also hits gene WSB2 439/440
(99 %)
0 diff
(100 %id)
DB570011.
matches multiple genes
hypothalamus .l-u 223 to 721 499 to 1     also hits gene WSB2 499/500
(99 %)
0 diff
(100 %id)
DB570769.
matches multiple genes
hypothalamus .l-u 223 to 684 462 to 1     also hits gene WSB2 462/463
(99 %)
1 diff
(99.8 %id)
DB573902.
matches multiple genes
hypothalamus .l-u 223 to 682 460 to 1   tiling clone, also hits gene WSB2 460/460
(100 %)
0 diff
(100 %id)
AA923149 carcinoid, lung .l-u 223 to 846 624 to 1       624/638
(97 %)
9 diff
(98.6 %id)
TI_149283150   .l-u 223 to 883 721 to 62       660/881
(74 %)
0 diff
(100 %id)
FN137248 breast carcinoma .l-u 224 to 298 1 to 72       72/73
(98 %)
4 diff
(94.6 %id)
DB535383 hippocampus .l-u 225 to 647 425 to 1       425/427
(99 %)
4 diff
(99.1 %id)
BP426200 small intestine .l-u 227 to 436 210 to 1       210/210
(100 %)
0 diff
(100 %id)
BP392361 pancreatic islet .l-u 229 to 725 499 to 1       499/499
(100 %)
2 diff
(99.6 %id)
TI_149306711   .l-u 229 to 883 716 to 63       654/1003
(65 %)
0 diff
(100 %id)
DB567528.
matches multiple genes
hypothalamus .l-u 230 to 697 468 to 1     also hits gene WSB2 468/469
(99 %)
1 diff
(99.8 %id)
TI_149281175   .l-u 242 to 844 607 to 5       603/694
(86 %)
0 diff
(100 %id)
TI_149304449   .l-u 247 to 883 699 to 63       637/1019
(62 %)
0 diff
(100 %id)
AA430637 ovarian tumor, ovary .l-u 251 to 671 1 to 421       421/422
(99 %)
1 diff
(99.8 %id)
BM978777 lung, Primary Lung Epithelial Cells .l-u 251 to 880 630 to 1       630/630
(100 %)
6 diff
(99.1 %id)
AA281878 germinal center B cell .l-u 290 to 527 1 to 239   fully sequenced,   239/239
(100 %)
0 diff
(100 %id)
CA311877 Human Lung Epithelial cells, lung .l-u 314 to 725 428 to 17   AAA   412/412
(100 %)
0 diff
(100 %id)
AW009595 colon .l-u 320 to 864 545 to 1       545/545
(100 %)
1 diff
(99.9 %id)
BF110766 carcinoid, lung .l-u 329 to 865 537 to 1       537/537
(100 %)
0 diff
(100 %id)
BU680059 lung, Primary Lung Epithelial Cells .l-u 329 to 880 552 to 1       552/552
(100 %)
0 diff
(100 %id)
BF438112 carcinoid, lung .l-u 331 to 866 536 to 1       536/536
(100 %)
0 diff
(100 %id)
BF438209 carcinoid, lung .l-u 334 to 869 536 to 1       536/536
(100 %)
0 diff
(100 %id)
BF832385 head_neck .l-u 346 to 566 1 to 220       220/220
(100 %)
3 diff
(98.7 %id)
AA759282 pooled .l-u 348 to 863 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AI829737 pooled .l-u 356 to 863 508 to 1       508/508
(100 %)
0 diff
(100 %id)
BE670340 carcinoid, lung .l-u 357 to 864 508 to 1       508/508
(100 %)
0 diff
(100 %id)
BF433864 carcinoid, lung .l-u 357 to 863 509 to 3       507/509
(99 %)
0 diff
(100 %id)
AI680994 carcinoid, lung .l-u 358 to 860 504 to 1       504/504
(100 %)
11 diff
(97.9 %id)
AW770949 carcinoid, lung .l-u 359 to 859 502 to 2       501/502
(99 %)
0 diff
(100 %id)
AI458480 carcinoid, lung .l-u 370 to 860 491 to 1       491/491
(100 %)
1 diff
(99.8 %id)
BE467748 carcinoid, lung .l-u 370 to 863 494 to 1       494/494
(100 %)
0 diff
(100 %id)
BG149344 carcinoid, lung .l-u 371 to 866 496 to 1       496/496
(100 %)
0 diff
(100 %id)
AI168745 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l-u 380 to 863 483 to 1       483/483
(100 %)
2 diff
(99.6 %id)
BF438138 carcinoid, lung .l-u 382 to 866 485 to 1       485/485
(100 %)
0 diff
(100 %id)
BE218410 carcinoid, lung .l-u 387 to 862 476 to 1       476/476
(100 %)
2 diff
(99.6 %id)
AA443653   .l-u 388 to 866 479 to 1   fully sequenced,   479/479
(100 %)
0 diff
(100 %id)
AI802019 carcinoid, lung .l-u 389 to 862 474 to 1       474/474
(100 %)
3 diff
(99.4 %id)
AW293357   .l-u 397 to 880 484 to 1       484/508
(95 %)
2 diff
(99.7 %id)
DB555921.
matches multiple genes
hypothalamus .l-u 405 to 860 459 to 1     also hits gene WSB2 459/459
(100 %)
10 diff
(97.9 %id)
DB559660.
matches multiple genes
hypothalamus .l-u 405 to 805 400 to 1     also hits gene WSB2 400/400
(100 %)
3 diff
(99.3 %id)
BF196156 carcinoid, lung .l-u 405 to 865 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BE669958 carcinoid, lung .l-u 406 to 866 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BE467207 carcinoid, lung .l-u 410 to 860 451 to 1       451/456
(98 %)
0 diff
(100 %id)
AI373702 uterus .l-u 412 to 863 452 to 1       452/452
(100 %)
0 diff
(100 %id)
BE468089 carcinoid, lung .l-u 416 to 860 443 to 1       443/443
(100 %)
5 diff
(98.9 %id)
AA740445 2 pooled tumors (clear cell type), Kidney .l-u 418 to 866 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
AW271263 Kidney .l-u 422 to 866 445 to 1       445/445
(100 %)
0 diff
(100 %id)
BE467441 carcinoid, lung .l-u 423 to 860 438 to 1       438/438
(100 %)
1 diff
(99.8 %id)
AI693252 carcinoid, lung .l-u 425 to 860 436 to 1       436/436
(100 %)
0 diff
(100 %id)
BE674136 carcinoid, lung .l-u 425 to 866 443 to 1       443/443
(100 %)
7 diff
(98.5 %id)
BU685362 lung, Primary Lung Epithelial Cells .l-u 430 to 880 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
AA935699 carcinoid, lung .l-u 433 to 862 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
CB068394 Pancreas, Purified pancreatic islet .l-u 438 to 864 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI218403 pooled .l-u 444 to 863 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AI694277 colon .l-u 444 to 864 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
AI693097 carcinoid, lung .l-u 444 to 860 417 to 1       417/417
(100 %)
4 diff
(99.1 %id)
EC488629 Prostate .l-u 451 to 556 1 to 104       104/104
(100 %)
8 diff
(92.4 %id)
BU607545 Human Lung Epithelial cells, lung .l-u 460 to 863 422 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 404/409
(98 %)
0 diff
(100 %id)
AA984017 carcinoid, lung .l-u 474 to 862 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AL037431 brain .l-u 491 to 874 383 to 1       383/388
(98 %)
1 diff
(99.8 %id)
FN068530 breast carcinoma .l-u 497 to 577 1 to 78       78/79
(98 %)
4 diff
(95.0 %id)
AA291947 germinal center B cell .l-u 497 to 863 367 to 1   fully sequenced,   367/367
(100 %)
0 diff
(100 %id)
AI268575 carcinoid, lung .l-u 501 to 860 360 to 1       360/360
(100 %)
0 diff
(100 %id)
AW204836   .l-u 504 to 880 377 to 1       377/377
(100 %)
0 diff
(100 %id)
BE669940 carcinoid, lung .l-u 524 to 999 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AI371465 brain, glioblastoma (pooled) .l-u 576 to 863 288 to 1       288/288
(100 %)
0 diff
(100 %id)
BF477854 carcinoid, lung .l-u 576 to 865 290 to 1       290/290
(100 %)
1 diff
(99.7 %id)
BX115338 whole brain .l-u 587 to 1117 14 to 543   tiling clone,   530/543
(97 %)
6 diff
(98.9 %id)
AW898542 nervous_normal .l-u 633 to 1012 10 to 390       381/412
(92 %)
24 diff
(94.2 %id)
AA743497 germinal center B cell .l-u 654 to 870 217 to 1       217/217
(100 %)
0 diff
(100 %id)
BE222400 carcinoid, lung .l-u 655 to 997 343 to 1       343/343
(100 %)
1 diff
(99.8 %id)
DB531814 hippocampus .l-u 661 to 1091 430 to 1       430/430
(100 %)
3 diff
(99.4 %id)
FN145115 breast carcinoma .l-u 700 to 795 1 to 98       98/98
(100 %)
4 diff
(96.0 %id)
F00291 leg muscle, skeletal muscle .l-u 705 to 959 1 to 256       256/256
(100 %)
2 diff
(99.3 %id)
AI630704 blood .l-u 708 to 863 181 to 26   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 156/156
(100 %)
0 diff
(100 %id)
FN101254 breast carcinoma .l-u 725 to 816 1 to 90       90/91
(98 %)
9 diff
(90.2 %id)
BG149431 carcinoid, lung .l-u 749 to 865 119 to 1       430/476
(90 %)
20 diff
(95.8 %id)
BM769657 stomach .l-u 766 to 1424 1 to 658       658/658
(100 %)
2 diff
(99.7 %id)
BM769972 stomach .l-u 766 to 1424 1 to 658       658/658
(100 %)
2 diff
(99.7 %id)
BQ082871 stomach .l-u 766 to 1237 1 to 471       471/471
(100 %)
5 diff
(99.0 %id)
BE503881 carcinoid, lung .l-u 779 to 997 220 to 1       220/220
(100 %)
1 diff
(99.6 %id)
BF802914 colon_ins .l-u 911 to 1335 1 to 425   tiling clone,   425/426
(99 %)
6 diff
(98.6 %id)
BE178765 head_neck .l-u 921 to 1203 1 to 283       283/283
(100 %)
13 diff
(95.5 %id)
BE827588 lung_tumor .l-u 1029 to 1237 1 to 208       208/208
(100 %)
3 diff
(98.6 %id)
AW605657 denis_drash .l-u 1078 to 1459 16 to 398       383/398
(96 %)
11 diff
(97.3 %id)
AW939438 denis_drash .l-u 1078 to 1459 16 to 398       383/398
(96 %)
11 diff
(97.3 %id)
W25818 eye, retina .l-u 1080 to 1579 15 to 516 F16L A17X M30X L44X L50P     502/550
(91 %)
9 diff
(98.4 %id)
AW939520 denis_drash .l-u 1081 to 1459 13 to 392       380/392
(96 %)
6 diff
(98.5 %id)
AW939581 denis_drash .l-u 1081 to 1459 13 to 392       380/392
(96 %)
6 diff
(98.5 %id)
BQ360892 ovary .l-u 1081 to 1296 1 to 217       217/225
(96 %)
6 diff
(97.4 %id)
BF885627 testis_normal .l-u 1136 to 1586 1 to 454 A27V F39Y     454/469
(96 %)
17 diff
(96.4 %id)
BQ447539 Knee, Osteoarthritic Cartilage .l-u 1225 to 1867 661 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
EC493244 Prostate .l-u 1282 to 1381 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
EC493806 Prostate .l-u 1282 to 1381 1 to 101       101/101
(100 %)
3 diff
(97.1 %id)
EC492037 Prostate .l-u 1359 to 1459 1 to 100       100/100
(100 %)
3 diff
(97.0 %id)
AI092526 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l-u 1398 to 1871 480 to 7   tiling clone,   474/480
(98 %)
0 diff
(100 %id)
BQ348010 head_neck .l-u 1430 to 1674 1 to 248       248/261
(95 %)
14 diff
(94.7 %id)
AA613988 adrenal adenoma, adrenal gland .l-u 1469 to 1859 409 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
EC460143 Prostate .l-u 1538 to 1648 1 to 112       112/117
(95 %)
2 diff
(98.3 %id)
EC489356 Prostate .l-u 1539 to 1653 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
EC518302 Prostate .l-u 1539 to 1648 1 to 108       108/113
(95 %)
3 diff
(97.4 %id)
EC532717 Prostate .l-u 1539 to 1653 1 to 113       113/113
(100 %)
2 diff
(98.3 %id)
EC533028 Prostate .l-u 1539 to 1648 1 to 110       110/115
(95 %)
1 diff
(99.2 %id)
EC547425 Prostate .l-u 1539 to 1653 1 to 113       113/113
(100 %)
2 diff
(98.3 %id)
EC576560 Prostate .l-u 1539 to 1648 1 to 109       109/114
(95 %)
2 diff
(98.3 %id)
EC489626 Prostate .l-u 1541 to 1648 1 to 108       108/113
(95 %)
6 diff
(94.7 %id)
AL562548 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .m 1 to 1020 1004 to 1 S74X tiling clone,   1004/1090
(92 %)
25 diff
(97.8 %id)
BE278529 choriocarcinoma, placenta .m 111 to 707 1 to 598 exact tiling clone,   598/598
(100 %)
1 diff
(99.9 %id)
BE732788 choriocarcinoma, placenta .m 111 to 906 1 to 787 C38V T39Q N40I F41S T42H ...     787/976
(80 %)
11 diff
(98.9 %id)
BF941463 brain, glioblastoma (pooled) .m 231 to 524 293 to 1       293/293
(100 %)
6 diff
(98.0 %id)
AA465179 germinal center B cell .m 248 to 525 282 to 5       278/282
(98 %)
0 diff
(100 %id)
BM822974 stomach .m 310 to 523 213 to 1     Submitted on the opposite strand 213/218
(97 %)
3 diff
(98.7 %id)
BM830191 stomach .m 310 to 523 214 to 1     Submitted on the opposite strand 214/219
(97 %)
2 diff
(99.1 %id)
BM829584 stomach .m 312 to 522 211 to 1     Submitted on the opposite strand 211/223
(94 %)
6 diff
(97.4 %id)
CX871490 embryonic stem .m 315 to 1093 799 to 21   tiling clone, AAA Submitted on the opposite strand 779/779
(100 %)
0 diff
(100 %id)
BM818558 stomach .m 321 to 495 175 to 1     Submitted on the opposite strand 175/175
(100 %)
8 diff
(95.5 %id)
TI_153989822   .m 466 to 1093 743 to 117   AAA   627/629
(99 %)
31 diff
(95.1 %id)
AW246653 lung, small cell carcinoma .m 570 to 1033 474 to 11   AAA   464/464
(100 %)
4 diff
(99.2 %id)
AI889747 adenocarcinoma, Pancreas .m 639 to 1093 480 to 26   AAA   455/455
(100 %)
2 diff
(99.6 %id)
AW205870   .m 654 to 1093 457 to 18   AAA   440/440
(100 %)
1 diff
(99.8 %id)
DB510100 testis .m 716 to 1094 1 to 379   tiling clone, Submitted on the opposite strand 379/380
(99 %)
5 diff
(98.7 %id)
AI864919 lymph node, lymphoma, follicular mixed small and largecell .n 1 to 363 399 to 37   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 363/363
(100 %)
2 diff
(99.5 %id)
BM505055 Pancreas, Purified pancreatic islet .n 87 to 672 1 to 586 exact tiling clone,   586/586
(100 %)
3 diff
(99.5 %id)
BM504734 Pancreas, Purified pancreatic islet .n 403 to 891 489 to 1   tiling clone,   489/489
(100 %)
2 diff
(99.6 %id)
AI491782 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .n 544 to 890 347 to 1       347/347
(100 %)
1 diff
(99.8 %id)
DA776954 brain .o 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
CV340848 prostate_tumor .p-u 1 to 150 7 to 154 F2A F6L A8P L9* tiling clone,   148/158
(93 %)
6 diff
(96.3 %id)
EH344173   .q-u 1 to 77 1 to 77 V9X tiling clone,   77/87
(88 %)
1 diff
(98.9 %id)
AA043667 uterus Gene RFC5, variant not shown         Suspected internal deletion, this clone was ignored    
AI738897 colon, colon tumor, RER+ Gene RFC5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BF128154 leiomyosarcoma cell line, uterus Gene RFC5, variant not shown         This clone was ignored    
BF128518 leiomyosarcoma cell line, uterus Gene RFC5, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k-u, .l-u, .m, .n, .o, .p-u, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI